Maite Mendioroz Iriarte holds a degree in Medicine and Surgery from the University of Navarra (1996) she completed her specialist training in Neurology (MIR) from Donostia University Hospital. She completed her training at Vall d’Hebron- Institut de Recerca Hospital (2006-2010), where she defended her doctoral thesis cum laude at UAB (2010). Between 2010 and 2012, she specialized in neuroepigenetics as a Visiting Scientist at Columbia University (New York). Since 2010, she has been part of the medical team of the Neurology Service at Navarra University Hospital (HUN), where she was Research Coordinator between 2016 and 2022. Since 2013, she has led the NeuroEpigenetics Unit of Navarrabiomed, combining her clinical work with research on neurodegenerative diseases, focusing on biomarkers and therapeutic targets.
She has participated in 26 research projects, serving as principal investigator in 11 (6 national and 5 regional). Her work has resulted in 107 scientific publications. She is a member of the ISCIII RICORS network of cerebrovascular diseases and to the national DEGESCO consortium.
She has tutored 12 neurology residents (2014-2019), led 5 doctoral theses, 5 master’s final projects, and 5 undergraduate projects. In addition, she was an associate clinical professor at the UNAV (2013-2022). Since 2022, she has served on the Management Committee of the EDONA Doctoral School of the UPNA.
Since 2022, she has been a member of the board of the Dementia Study Group of the Spanish Society of Neurology. She has evaluated projects for the State Agency for Research and participated in the CTEs of the ISCIII as a panel adjunct. Among her recognitions are the National Award Alberto Rábano (2011), her appointment as an Honorary Member of the European Council of Doctors (2018), the TELVA Science Award (2018), and her inclusion in the Top 100 Women Leaders in Spain ranking (2021).
In addition, she served as Director of Navarrabiomed–Miguel Servet Foundation between 2022 and 2024, consolidating her position as a leading researcher and specific manager in research and management in neuroscience and epigenetics.
